SPARC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sun Pharma Advanced Research Co Ltd

Watchlist Manager

Watchlist

Price: 208.79 INR -2.05%

Market Cap: ₹67.8B

S	Sun Pharma Advanced Research Co Ltd NSE:SPARC	IN
	Southern Co NYSE:SO	US
F	Fresenius Medical Care AG & Co KGaA XETRA:FME	DE
	Hisamitsu Pharmaceutical Co Inc TSE:4530	JP
F	Ford Motor Co SWB:FMC1	US
	RT Minerals Corp F:S6O	CA
	Innospec Inc NASDAQ:IOSP	US
C	City Developments Ltd XBER:CDE	SG
	Goliath Resources Ltd F:B4IF	CA
	Comp SA F:Q3W	PL

Profitability Summary

Sun Pharma Advanced Research Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Sustainable 3Y Average Gross Margin

41%

Gross Margin is Increasing

91% > 98%

Exceptional Operating Margin

85%

Negative 3Y Average Operating Margin

-399%

Operating Margin is Increasing

-107% > 85%

Exceptional Net Margin

83%

Negative 3Y Average Net Margin

-397%

Net Margin is Increasing

-101% > 83%

Negative Free Cash Flow Margin

-14%

Negative 3Y Average Free Cash Flow Margin

-438%

Free Cash Flow Margin is Increasing

-36% > -14%

Exceptional ROE

277%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-180%

ROIC is Increasing

-107% > 139%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.